Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer
- 1 October 1999
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (10) , 3048-3057
- https://doi.org/10.1200/jco.1999.17.10.3048
Abstract
PURPOSE: To study interactions between disease-free survival (DFS) and four components of the plasminogen activator system: urokinase-type plasminogen activator (uPA), its two inhibitors (PAI-1 and...Keywords
This publication has 38 references indexed in Scilit:
- Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissuesBreast Cancer Research and Treatment, 1996
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Prognostic factor clustering in breast cancer: Biology or chronology?European Journal Of Cancer, 1995
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995
- Plasminogen activator system in human breast cancerInternational Journal of Cancer, 1992
- Fisher's Optimal Scores and Multiple Correspondence AnalysisPublished by JSTOR ,1990
- Nuclear characteristics as indicators of prognosis in node negative breast cancer patientsBreast Cancer Research and Treatment, 1989
- Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascadeCell, 1986
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstitutePublished by Elsevier ,1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958